On Monday, generic drug maker Actavis Inc. (NYSE: ACT) announced plans to purchase specialty pharmaceutical company Warner Chilcott (NASDAQ: WCRX) in an all-stock deal valued around $8.5 billion. Actavis management will …
(Reuters) - Generic drugmaker Actavis Inc ACT.N, which has been the subject of takeover speculation, plans to buy specialty pharmaceutical company Warner Chilcott Plc WCRX.O for $5 billion (3.2 billion pounds) in stock. The …
Men’s Wearhouse Inc. (NYSE: MW) named value stock of the day at Zacks ... Warner Chilcott plc (NASDAQ: WCRX) …
U.S. stock futures were barely lower ahead of the open. But shares of Yahoo (YHOO) slumped after the Tumblr deal was made official. Earlier, shares were up more than 2%. Actavis (ACT) shares jumped after the drug company it would buy …
Earnings, or profits, drive stock prices. The market values a company based on its ... Warner Chilcott Limited …
Year-to-date, the stock has now gained more than 57.10%, easily outperforming the broad market. Its MACD chart suggests that market sentiment is currently bullish. Download the free research on WCRX today by registering at …
For 2010, funds based on select stock indexes have dominated the successful choices ... Wells Fargo & Co. (WFC), Waste Management Inc. (WM) and Warner Chilcott plc (WCRX), which is a pharmaceutical company based in Ardee, …
Canadian drugmaker Valeant Pharmaceuticals International (NYSE ... Last Monday, Actavis said it will buy Warner …
DUBLIN, Oct. 1, 2013 /PRNewswire/ -- Actavis plc (NYSE: ACT) ("Actavis") today announced that it has completed the acquisition of Warner Chilcott plc (NASDAQ: WCRX) ("Warner Chilcott") in a stock-for-stock transaction valued at …
Mylan’s cash and stock bid for its larger rival, which came in early last week, valued Actavis at $120 per share, the person said, asking not to be identified because the matter is not public. The Mylan offer came shortly after Actavis halted …